Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Industry: Pharma & Healthcare

Published Date: 2024-04-16

Pages: 137 Pages

Report ld: 2682493

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Human Prothrombin Complex Market Size(US$)

CAGR 2024-2030

11.8%

Market Size,2030

USD 3,473.8

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 1,778.9 million

Market Forecast in 2030(Value)

US$ 3,473.8 million

CAGR

11.8%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

The global Human Prothrombin Complex market is projected to reach US$ 3473.8 million by 2030 from an estimated US$ 1778.9 million in 2024, at a CAGR of 11.8% during 2024 and 2030.

Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.

MARKET SEGMENTATION

By Company

Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others

Segment by Application

Hemophilia B
Vitamin K Deficiency
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.

The Human Prothrombin Complex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Prothrombin Complex market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Prothrombin Complex manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Human Prothrombin Complex in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Prothrombin Complex sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: Research Findings and Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Human Prothrombin Complex Product Introduction

1.2 Market by Type

1.2.1 Global Human Prothrombin Complex Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 500 IU/Vial

1.2.3 600 IU/Vial

1.2.4 1000 IU/Vial

1.2.5 Others

1.3 Market by Application

1.3.1 Global Human Prothrombin Complex Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Hemophilia B

1.3.3 Vitamin K Deficiency

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Human Prothrombin Complex Market Size Estimates and Forecasts

2.1.1 Global Human Prothrombin Complex Revenue 2019-2030

2.1.2 Global Human Prothrombin Complex Sales 2019-2030

2.2 Human Prothrombin Complex Market Size by Region: 2023 Versus 2030

2.3 Human Prothrombin Complex Sales by Region (2019-2030)

2.3.1 Global Human Prothrombin Complex Sales by Region: 2019-2024

2.3.2 Global Human Prothrombin Complex Sales Forecast by Region (2025-2030)

2.3.3 Global Human Prothrombin Complex Sales Market Share by Region (2019-2030)

2.4 Human Prothrombin Complex Market Estimates and Projections by Region (2025-2030)

2.4.1 Global Human Prothrombin Complex Revenue by Region: 2019-2024

2.4.2 Global Human Prothrombin Complex Revenue Forecast by Region (2025-2030)

2.4.3 Global Human Prothrombin Complex Revenue Market Share by Region (2019-2030)

3 Global Human Prothrombin Complex by Manufacturers

3.1 Global Top Human Prothrombin Complex Manufacturers by Sales

3.1.1 Global Human Prothrombin Complex Sales by Manufacturer (2019-2024)

3.1.2 Global Human Prothrombin Complex Sales Market Share by Manufacturer (2019-2024)

3.2 Global Top Human Prothrombin Complex Manufacturers by Revenue

3.2.1 Global Human Prothrombin Complex Revenue by Manufacturer (2019-2024)

3.2.2 Global Human Prothrombin Complex Revenue Share by Manufacturer (2019-2024)

3.3 Global Human Prothrombin Complex Price by Manufacturer (2019-2024)

3.4 Competitive Landscape

3.4.1 Key Human Prothrombin Complex Manufacturers Covered: Ranking by Revenue

3.4.2 Global Human Prothrombin Complex Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.4.3 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Human Prothrombin Complex Manufacturing Base Distribution, Product Type

3.5.1 Human Prothrombin Complex Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Human Prothrombin Complex Product Type

3.5.3 Date of International Manufacturers Enter into Human Prothrombin Complex Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 Takeda

4.1.1 Takeda Company Information

4.1.2 Takeda Description, Business Overview

4.1.3 Takeda Human Prothrombin Complex Products Offered

4.1.4 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

4.1.5 Takeda Human Prothrombin Complex Sales by Product in 2023

4.1.6 Takeda Human Prothrombin Complex Sales by Application in 2023

4.1.7 Takeda Human Prothrombin Complex Sales by Geographic Area in 2023

4.1.8 Takeda Recent Developments

4.2 CSL

4.2.1 CSL Company Information

4.2.2 CSL Description, Business Overview

4.2.3 CSL Human Prothrombin Complex Products Offered

4.2.4 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

4.2.5 CSL Human Prothrombin Complex Sales by Product in 2023

4.2.6 CSL Human Prothrombin Complex Sales by Application in 2023

4.2.7 CSL Human Prothrombin Complex Sales by Geographic Area in 2023

4.2.8 CSL Recent Developments

4.3 Grifols

4.3.1 Grifols Company Information

4.3.2 Grifols Description, Business Overview

4.3.3 Grifols Human Prothrombin Complex Products Offered

4.3.4 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

4.3.5 Grifols Human Prothrombin Complex Sales by Product in 2023

4.3.6 Grifols Human Prothrombin Complex Sales by Application in 2023

4.3.7 Grifols Human Prothrombin Complex Sales by Geographic Area in 2023

4.3.8 Grifols Recent Developments

4.4 Octapharma

4.4.1 Octapharma Company Information

4.4.2 Octapharma Description, Business Overview

4.4.3 Octapharma Human Prothrombin Complex Products Offered

4.4.4 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

4.4.5 Octapharma Human Prothrombin Complex Sales by Product in 2023

4.4.6 Octapharma Human Prothrombin Complex Sales by Application in 2023

4.4.7 Octapharma Human Prothrombin Complex Sales by Geographic Area in 2023

4.4.8 Octapharma Recent Developments

4.5 Hualan Biological

4.5.1 Hualan Biological Company Information

4.5.2 Hualan Biological Description, Business Overview

4.5.3 Hualan Biological Human Prothrombin Complex Products Offered

4.5.4 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

4.5.5 Hualan Biological Human Prothrombin Complex Sales by Product in 2023

4.5.6 Hualan Biological Human Prothrombin Complex Sales by Application in 2023

4.5.7 Hualan Biological Human Prothrombin Complex Sales by Geographic Area in 2023

4.5.8 Hualan Biological Recent Developments

4.6 Meheco Xinxing Pharma

4.6.1 Meheco Xinxing Pharma Company Information

4.6.2 Meheco Xinxing Pharma Description, Business Overview

4.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Products Offered

4.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2019-2024)

4.6.5 Meheco Xinxing Pharma Human Prothrombin Complex Sales by Product in 2023

4.6.6 Meheco Xinxing Pharma Human Prothrombin Complex Sales by Application in 2023

4.6.7 Meheco Xinxing Pharma Human Prothrombin Complex Sales by Geographic Area in 2023

4.6.8 Meheco Xinxing Pharma Recent Development

5 Breakdown Data by Type

5.1 Global Human Prothrombin Complex Sales by Type (2019-2030)

5.1.1 Global Human Prothrombin Complex Sales by Type (2019-2024)

5.1.2 Global Human Prothrombin Complex Sales Forecast by Type (2025-2030)

5.1.3 Global Human Prothrombin Complex Sales Market Share by Type (2019-2030)

5.2 Global Human Prothrombin Complex Revenue Forecast by Type (2019-2030)

5.2.1 Global Human Prothrombin Complex Revenue by Type (2019-2024)

5.2.2 Global Human Prothrombin Complex Revenue Forecast by Type (2025-2030)

5.2.3 Global Human Prothrombin Complex Revenue Market Share by Type (2019-2030)

5.3 Human Prothrombin Complex Average Selling Price (ASP) by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Human Prothrombin Complex Sales by Application (2019-2030)

6.1.1 Global Human Prothrombin Complex Sales by Application (2019-2024)

6.1.2 Global Human Prothrombin Complex Sales Forecast by Application (2025-2030)

6.1.3 Global Human Prothrombin Complex Sales Market Share by Application (2019-2030)

6.2 Global Human Prothrombin Complex Revenue Forecast by Application (2019-2030)

6.2.1 Global Human Prothrombin Complex Revenue by Application (2019-2024)

6.2.2 Global Human Prothrombin Complex Revenue Forecast by Application (2025-2030)

6.2.3 Global Human Prothrombin Complex Revenue Market Share by Application (2019-2030)

6.3 Human Prothrombin Complex Average Selling Price (ASP) by Application (2019-2030)

7 North America

7.1 North America Human Prothrombin Complex Market Size YoY Growth 2019-2030

7.2 North America Human Prothrombin Complex Market Facts & Figures by Country

7.2.1 North America Human Prothrombin Complex Sales by Country (2019-2030)

7.2.2 North America Human Prothrombin Complex Revenue by Country (2019-2030)

7.3 North America Human Prothrombin Complex Sales by Type (2019-2024)

7.4 North America Human Prothrombin Complex Sales by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Human Prothrombin Complex Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Human Prothrombin Complex Market Facts & Figures by Region

8.2.1 Asia-Pacific Human Prothrombin Complex Sales by Region (2019-2030)

8.2.2 Asia-Pacific Human Prothrombin Complex Revenue by Region (2019-2030)

8.3 Asia-Pacific Human Prothrombin Complex Sales by Type (2019-2024)

8.4 Asia-Pacific Human Prothrombin Complex Sales by Application (2019-2024)

9 Europe

9.1 Europe Human Prothrombin Complex Market Size YoY Growth 2019-2030

9.2 Europe Human Prothrombin Complex Market Facts & Figures by Country

9.2.1 Europe Human Prothrombin Complex Sales by Country (2019-2030)

9.2.2 Europe Human Prothrombin Complex Revenue by Country (2019-2030)

9.3 Europe Human Prothrombin Complex Sales by Type (2019-2024)

9.4 Europe Human Prothrombin Complex Sales by Application (2019-2024)

10 Latin America

10.1 Latin America Human Prothrombin Complex Market Size YoY Growth 2019-2030

10.2 Latin America Human Prothrombin Complex Market Facts & Figures by Country

10.2.1 Latin America Human Prothrombin Complex Sales by Country (2019-2030)

10.2.2 Latin America Human Prothrombin Complex Revenue by Country (2019-2030)

10.3 Latin America Human Prothrombin Complex Sales by Type (2019-2024)

10.4 Latin America Human Prothrombin Complex Sales by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Human Prothrombin Complex Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Human Prothrombin Complex Market Facts & Figures by Country

11.2.1 Middle East and Africa Human Prothrombin Complex Sales by Country (2019-2030)

11.2.2 Middle East and Africa Human Prothrombin Complex Revenue by Country (2019-2030)

11.3 Middle East and Africa Human Prothrombin Complex Sales by Type (2019-2024)

11.4 Middle East and Africa Human Prothrombin Complex Sales by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Human Prothrombin Complex Supply Chain Analysis

12.2 Human Prothrombin Complex Key Raw Materials and Upstream Suppliers

12.3 Human Prothrombin Complex Clients Analysis

12.4 Human Prothrombin Complex Sales Channel and Sales Model Analysis

12.4.1 Human Prothrombin Complex Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Human Prothrombin Complex Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Human Prothrombin Complex Distributors

13 Market Dynamics

13.1 Human Prothrombin Complex Industry Trends

13.2 Human Prothrombin Complex Market Drivers

13.3 Human Prothrombin Complex Market Challenges

13.4 Human Prothrombin Complex Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Human Prothrombin Complex Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Manufacturers of 500 IU/Vial

Table 3. Major Manufacturers of 600 IU/Vial

Table 4. Major Manufacturers of 1000 IU/Vial

Table 5. Major Manufacturers of Others

Table 6. Global Human Prothrombin Complex Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Human Prothrombin Complex Market Size by Region (US$ Million): 2023 VS 2030

Table 8. Global Human Prothrombin Complex Sales by Region (2019-2024) & (K Units)

Table 9. Global Human Prothrombin Complex Sales Forecast by Region (2025-2030) & (K Units)

Table 10. Global Human Prothrombin Complex Revenue by Region (2019-2024) & (US$ Million)

Table 11. Global Human Prothrombin Complex Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 12. Global Human Prothrombin Complex Sales by Manufacturer (2019-2024) & (K Units)

Table 13. Global Human Prothrombin Complex Sales Share by Manufacturer (2019-2024)

Table 14. Human Prothrombin Complex Revenue by Manufacturer (2019-2024) & (US$ Million)

Table 15. Human Prothrombin Complex Revenue Share by Manufacturer (2019-2024)

Table 16. Key Manufacturers Human Prothrombin Complex Price (2019-2024) & (M USD/Unit)

Table 17. Ranking of Global Top Human Prothrombin Complex Manufacturers by Revenue (US$ Million) in 2023

Table 18. Global Human Prothrombin Complex Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 19. Global Human Prothrombin Complex by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2023)

Table 20. Human Prothrombin Complex Manufacturers Manufacturing Base Distribution and Headquarters

Table 21. Manufacturers Human Prothrombin Complex Product Type

Table 22. Date of International Manufacturers Enter into Human Prothrombin Complex Market

Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 24. Takeda Company Information

Table 25. Takeda Description and Business Overview

Table 26. Takeda Human Prothrombin Complex Product

Table 27. Takeda Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 28. Takeda Sales Proportion of Human Prothrombin Complex by Product in 2023

Table 29. Takeda Sales Proportion of Human Prothrombin Complex by Application in 2023

Table 30. Takeda Sales Proportion of Human Prothrombin Complex by Geographic Area in 2023

Table 31. Takeda Recent Development

Table 32. CSL Company Information

Table 33. CSL Description and Business Overview

Table 34. CSL Human Prothrombin Complex Product

Table 35. CSL Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 36. CSL Sales Proportion of Human Prothrombin Complex by Product in 2023

Table 37. CSL Sales Proportion of Human Prothrombin Complex by Application in 2023

Table 38. CSL Sales Proportion of Human Prothrombin Complex by Geographic Area in 2023

Table 39. CSL Recent Development

Table 40. Grifols Company Information

Table 41. Grifols Description and Business Overview

Table 42. Grifols Human Prothrombin Complex Product

Table 43. Grifols Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 44. Grifols Sales Proportion of Human Prothrombin Complex by Product in 2023

Table 45. Grifols Sales Proportion of Human Prothrombin Complex by Application in 2023

Table 46. Grifols Sales Proportion of Human Prothrombin Complex by Geographic Area in 2023

Table 47. Grifols Recent Development

Table 48. Octapharma Company Information

Table 49. Octapharma Description and Business Overview

Table 50. Octapharma Human Prothrombin Complex Product

Table 51. Octapharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 52. Octapharma Sales Proportion of Human Prothrombin Complex by Product in 2023

Table 53. Octapharma Sales Proportion of Human Prothrombin Complex by Application in 2023

Table 54. Octapharma Sales Proportion of Human Prothrombin Complex by Geographic Area in 2023

Table 55. Octapharma Recent Development

Table 56. Hualan Biological Company Information

Table 57. Hualan Biological Description and Business Overview

Table 58. Hualan Biological Human Prothrombin Complex Product

Table 59. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 60. Hualan Biological Sales Proportion of Human Prothrombin Complex by Product in 2023

Table 61. Hualan Biological Sales Proportion of Human Prothrombin Complex by Application in 2023

Table 62. Hualan Biological Sales Proportion of Human Prothrombin Complex by Geographic Area in 2023

Table 63. Hualan Biological Recent Development

Table 64. Meheco Xinxing Pharma Company Information

Table 65. Meheco Xinxing Pharma Description and Business Overview

Table 66. Meheco Xinxing Pharma Human Prothrombin Complex Product

Table 67. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2019-2024)

Table 68. Meheco Xinxing Pharma Sales Proportion of Human Prothrombin Complex by Product in 2023

Table 69. Meheco Xinxing Pharma Sales Proportion of Human Prothrombin Complex by Application in 2023

Table 70. Meheco Xinxing Pharma Sales Proportion of Human Prothrombin Complex by Geographic Area in 2023

Table 71. Meheco Xinxing Pharma Recent Development

Table 72. Global Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)

Table 73. Global Human Prothrombin Complex Sales Forecast by Type (2025-2030) & (K Units)

Table 74. Global Human Prothrombin Complex Revenue by Type (2019-2024) & (US$ Million)

Table 75. Global Human Prothrombin Complex Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 76. Global Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)

Table 77. Global Human Prothrombin Complex Sales Forecast by Application (2025-2030) & (K Units)

Table 78. Global Human Prothrombin Complex Revenue by Application (2019-2024) & (US$ Million)

Table 79. Global Human Prothrombin Complex Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 80. North America Human Prothrombin Complex Sales by Country (2019-2024) & (K Units)

Table 81. North America Human Prothrombin Complex Sales by Country (2025-2030) & (K Units)

Table 82. North America Human Prothrombin Complex Revenue by Country (2019-2024) & (US$ Million)

Table 83. North America Human Prothrombin Complex Revenue by Country (2025-2030) & (US$ Million)

Table 84. North America Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)

Table 85. North America Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)

Table 86. Asia-Pacific Human Prothrombin Complex Sales by Region (2019-2024) & (K Units)

Table 87. Asia-Pacific Human Prothrombin Complex Sales by Region (2025-2030) & (K Units)

Table 88. Asia-Pacific Human Prothrombin Complex Revenue by Region (2019-2030) & (US$ Million)

Table 89. Asia-Pacific Human Prothrombin Complex Revenue by Region (2025-2030) & (US$ Million)

Table 90. Asia-Pacific Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)

Table 91. Asia-Pacific Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)

Table 92. Europe Human Prothrombin Complex Sales by Country (2019-2024) & (K Units)

Table 93. Europe Human Prothrombin Complex Sales by Country (2025-2030) & (K Units)

Table 94. Europe Human Prothrombin Complex Revenue by Country (2019-2024) & (US$ Million)

Table 95. Europe Human Prothrombin Complex Revenue by Country (2025-2030) & (US$ Million)

Table 96. Europe Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)

Table 97. Europe Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)

Table 98. Latin America Human Prothrombin Complex Sales by Country (2019-2024) & (K Units)

Table 99. Latin America Human Prothrombin Complex Sales by Country (2025-2030) & (K Units)

Table 100. Latin America Human Prothrombin Complex Revenue by Country (2019-2024) & (US$ Million)

Table 101. Latin America Human Prothrombin Complex Revenue by Country (2025-2030) & (US$ Million)

Table 102. Latin America Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)

Table 103. Latin America Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)

Table 104. Middle East and Africa Human Prothrombin Complex Sales by Country (2019-2024) & (K Units)

Table 105. Middle East and Africa Human Prothrombin Complex Sales by Country (2025-2030) & (K Units)

Table 106. Middle East and Africa Human Prothrombin Complex Revenue by Country (2019-2024) & (US$ Million)

Table 107. Middle East and Africa Human Prothrombin Complex Revenue by Country (2025-2030) & (US$ Million)

Table 108. Middle East and Africa Human Prothrombin Complex Sales by Type (2019-2024) & (K Units)

Table 109. Middle East and Africa Human Prothrombin Complex Sales by Application (2019-2024) & (K Units)

Table 110. Human Prothrombin Complex Key Raw Materials, Industry Status and Trend

Table 111. Human Prothrombin Complex Key Raw Materials and Upstream Suppliers

Table 112. Human Prothrombin Complex Clients Status and Trend

Table 113. Human Prothrombin Complex Typical Clients

Table 114. Human Prothrombin Complex Distributors

Table 115. Human Prothrombin Complex Market Trends

Table 116. Human Prothrombin Complex Market Drivers

Table 117. Human Prothrombin Complex Market Challenges

Table 118. Human Prothrombin Complex Market Restraints

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Prothrombin Complex Product Picture

Figure 2. Global Human Prothrombin Complex Sales Market Share by Type in 2023 & 2030

Figure 3. 500 IU/Vial Product Picture

Figure 4. 600 IU/Vial Product Picture

Figure 5. 1000 IU/Vial Product Picture

Figure 6. Others Product Picture

Figure 7. Global Human Prothrombin Complex Sales Market Share by Application in 2023 & 2030

Figure 8. Hemophilia B Examples

Figure 9. Vitamin K Deficiency Examples

Figure 10. Others Examples

Figure 11. Human Prothrombin Complex Report Years Considered

Figure 12. Global Human Prothrombin Complex Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Human Prothrombin Complex Market Size 2019-2030 (US$ Million)

Figure 14. Global Human Prothrombin Complex Sales 2019-2030 (K Units)

Figure 15. Global Human Prothrombin Complex Sales Market Share Forecast by Region (2019-2030)

Figure 16. Global Human Prothrombin Complex Revenue Market Share by Region (2019-2030)

Figure 17. Global Human Prothrombin Complex Sales Share by Manufacturer in 2023

Figure 18. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Human Prothrombin Complex Sales Market Share Forecast by Type (2019-2030)

Figure 20. Global Human Prothrombin Complex Revenue Market Share Forecast by Type (2019-2030)

Figure 21. Human Prothrombin Complex Average Selling Price (ASP) by Type (2019-2024) & (M USD/Unit)

Figure 22. Global Human Prothrombin Complex Sales Market Share Forecast by Application (2019-2030)

Figure 23. Global Human Prothrombin Complex Revenue Market Share Forecast by Application (2019-2030)

Figure 24. Human Prothrombin Complex Average Selling Price (ASP) by Application (2019-2024) & (M USD/Unit)

Figure 25. North America Human Prothrombin Complex Revenue 2019-2030 (US$ Million)

Figure 26. North America Human Prothrombin Complex Sales Market Share by Type (2019-2024)

Figure 27. North America Human Prothrombin Complex Sales Market Share by Application (2019-2024)

Figure 28. Asia-Pacific Human Prothrombin Complex Revenue 2019-2030 (US$ Million)

Figure 29. Asia-Pacific Human Prothrombin Complex Sales Market Share by Region (2019-2030)

Figure 30. Asia-Pacific Human Prothrombin Complex Revenue Market Share by Region (2019-2030)

Figure 31. Asia-Pacific Human Prothrombin Complex Sales Market Share by Type (2019-2024)

Figure 32. Asia-Pacific Human Prothrombin Complex Sales Market Share by Application (2019-2024)

Figure 33. Europe Human Prothrombin Complex Revenue Growth Rate 2019-2030 (US$ Million)

Figure 34. Europe Human Prothrombin Complex Sales Market Share by Country (2019-2030)

Figure 35. Europe Human Prothrombin Complex Revenue Market Share by Country (2019-2030)

Figure 36. Europe Human Prothrombin Complex Sales Market Share by Type (2019-2024)

Figure 37. Europe Human Prothrombin Complex Sales Market Share by Application (2019-2024)

Figure 38. Latin America Human Prothrombin Complex Revenue Growth Rate 2019-2030 (US$ Million)

Figure 39. Latin America Human Prothrombin Complex Sales Market Share by Country (2019-2030)

Figure 40. Latin America Human Prothrombin Complex Revenue Market Share by Country (2019-2024)

Figure 41. Latin America Human Prothrombin Complex Sales Market Share by Type (2019-2024)

Figure 42. Latin America Human Prothrombin Complex Sales Market Share by Application (2019-2024)

Figure 43. Middle East and Africa Human Prothrombin Complex Revenue Growth Rate 2019-2030 (US$ Million)

Figure 44. Middle East and Africa Human Prothrombin Complex Sales Market Share by Country (2019-2030)

Figure 45. Middle East and Africa Human Prothrombin Complex Revenue Market Share by Country (2019-2030)

Figure 46. Middle East and Africa Human Prothrombin Complex Sales Market Share by Type (2019-2024)

Figure 47. Middle East and Africa Human Prothrombin Complex Sales Market Share by Application (2019-2024)

Figure 48. Human Prothrombin Complex Supply Chain (Upstream and Downstream Market)

Figure 49. Global Production Market Share of Human Prothrombin Complex Raw Materials by Region in 2023

Figure 50. Human Prothrombin Complex Distribution Channels

Figure 51. Global Human Prothrombin Complex Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 52. Global Human Prothrombin Complex Percentage 2019-2030: Online Sales VS Offline Sales

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Human Prothrombin Complex market? zhanKai

The top companies in the global Human Prothrombin Complex market are Takeda、CSL、Grifols.

What was the global market size of Human Prothrombin Complex in 2030? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Human Prothrombin Complex in 2024? shouQi

What is the annual compound growth rate of the global Human Prothrombin Complex market size from 2024 to 2030? shouQi

Related Reports

Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 146
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)

Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
USD 4250.00 (Single User License)
Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 2900.00 (Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
USD 3950.00 (Single User License)
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 146
USD 4900.00 (Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 100
USD 3950.00 (Single User License)
Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published: 2025-01-16
Pages: 86
USD 2900.00 (Single User License)
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-07
Pages: 90
USD 4900.00 (Single User License)